MDxHealth SA - ADR
NASDAQ:MDXH
| Market Cap (Intraday) | 73.82M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $2.88 |
| 50-Day MA | $3.35 |
| 200-Day MA | $4.17 |
MDxHealth SA - ADR Stock, NASDAQ:MDXH
CAP Business Center, Rue d'Abhooz, 31, Herstal, Walloon Region 4040
Belgium
Phone: +32.4.257.70.71
Number of Employees: 258
Description
MDxHealth SA is a commercial-stage precision diagnostics company, which engages in the development and commercialization of molecular diagnostic products for personalized cancer treatment. It operates through the following geographical segments: United States of America, The Netherlands, Belgium, Spain, Poland, Italy, Rest of EU, and Rest of the World. The firm offers ConfirmMDx, SelectMDx, AssureMDx, InformMDx, SelectMDx, and MonitorMDx. The company was founded by Herman Spolders and Philip S. Devine on January 10, 2003 and is headquartered in Herstal, Belgium.